EUVIMEDEUVIMED entdecken
Crossref

Outcomes of kidney transplant recipients exposed to Chagas disease under Benznidazole prophylaxis. A single center 10‐year experience

Maria L Budel iD, Ana P Alegretti, Natália P Prado, Fabiani P Machado, Andrea C Bauer, Roberto C Manfro

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Maria L Budel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Nitroimidazoles, Kidney Transplantation, Chagas Disease, Trypanosoma cruzi. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chagas disease (ChD) is endemic in many parts of the world and can be transmitted through organ transplantation or reactivated by immunosuppression. Organs from infected donors are occasionally used for transplantation, and the best way of managing the recipients remains a subject of debate.

Methods

We present a single‐center cohort study describing a 10‐year experience of kidney transplantation in patients at risk of donor‐derived ChD and or reactivation. Patients received prophylactic treatment with Benznidazole and were monitored for transmission or reactivation. Monitoring included assessing direct parasitemia, serology, and polymerase chain reaction (PCR).

Results

Fifty‐seven kidney transplant recipients (KTRs) were enrolled in the study. Forty‐four patients (77.2%) were at risk of primary ChD infection, nine patients (15.8%) were at risk of disease reactivation, and four patients (7.0%) were at risk of both. All patients received Benznidazole prophylaxis, starting on the first day after transplantation. Parasitemia was assessed in 51 patients (89.5%), serology also in 51 patients (89.5%), and PCR in 40 patients (70.2%). None of the patients exhibited clinically or laboratory‐detectable signs of disease. A single patient experienced a significant side effect, a cutaneous rash with intense pruritus. At 1‐year post‐transplantation, the patient and graft survival rates were 96.5% and 93%, respectively.

Conclusion

In this study, no donor‐derived or reactivation of Trypanosoma cruzi infection occurred in KTRs receiving Benznidazole prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NitroimidazolesKidney TransplantationChagas DiseaseTrypanosoma cruziTrypanocidal AgentsHumansMaleFemaleMiddle AgedAdultParasitemiaAgedTransplant RecipientsTreatment OutcomeCohort StudiesTissue Donors

Stichwörter der Autor:innen

Chagas diseasebenznidazoleprophylaxisrenal transplantation

Substanzen

NitroimidazolesbenzonidazoleTrypanocidal Agents

Autor:innen und Institutionen

  • Division of Nephrology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Division of Laboratory Medicine, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Division of Transplantation, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • Division of Medical College, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

ORCID-Profile: Maria L Budel

Zitieren

APA

Budel, M. L., Alegretti, A. P., Prado, N. P., Machado, F. P., Bauer, A. C., & Manfro, R. C. (2024). Outcomes of kidney transplant recipients exposed to Chagas disease under Benznidazole prophylaxis. A single center 10‐year experience. Transplant Infectious Disease. https://doi.org/10.1111/tid.14336

Vancouver

Budel ML, Alegretti AP, Prado NP, Machado FP, Bauer AC, Manfro RC. Outcomes of kidney transplant recipients exposed to Chagas disease under Benznidazole prophylaxis. A single center 10‐year experience. Transplant Infectious Disease. 2024. doi:10.1111/tid.14336

BibTeX
@article{Budel2024,
  author = {Budel, Maria L and Alegretti, Ana P and Prado, Natália P and Machado, Fabiani P and Bauer, Andrea C and Manfro, Roberto C},
  title = {Outcomes of kidney transplant recipients exposed to Chagas disease under Benznidazole prophylaxis. A single center 10‐year experience},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14336}
}
Kostenlos starten →